DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 1 filers reported holding DERMA SCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 60 | -80.6% | 0.00% | – |
| Q3 2016 | $1,000 | -87.5% | 309 | -84.5% | 0.00% | – |
| Q2 2016 | $8,000 | -27.3% | 1,999 | -26.0% | 0.00% | – |
| Q3 2015 | $11,000 | -21.4% | 2,700 | +35.0% | 0.00% | – |
| Q2 2015 | $14,000 | -74.5% | 2,000 | -71.4% | 0.00% | – |
| Q1 2015 | $55,000 | +358.3% | 6,986 | +442.0% | 0.00% | – |
| Q4 2014 | $12,000 | +100.0% | 1,289 | +70.7% | 0.00% | – |
| Q3 2014 | $6,000 | +50.0% | 755 | +101.3% | 0.00% | – |
| Q2 2014 | $4,000 | -33.3% | 375 | -28.2% | 0.00% | – |
| Q1 2014 | $6,000 | +100.0% | 522 | +72.3% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 303 | +118.0% | 0.00% | – |
| Q3 2013 | $2,000 | -33.3% | 139 | -31.2% | 0.00% | – |
| Q2 2013 | $3,000 | – | 202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |